Drug Research
5 FDA Announcements To Pay Attention To In The 2023 Q1
The biotechnology sector had a decline in 2022 that went beyond just falling stock prices. Additionally, only 37 new drugs were approved by the FDA's primary review office last year, the lowest number since 2016.
Yet there is cause for...
Drug Research
Watch Out For These Potential Best-Seller Drugs In 2023
In the 70 pharmaceuticals featured in Clarivate Plc's Drugs to WatchTM 2023 study, comprising potential blockbuster drugs, the bulk were found to be personalised medicines.
The report provides a predicted analysis of new medication launches or major indication launches in...
Drug Research
Study Reveals That Gut Microbiome Is Crucial In Parkinsons
Metagenomics, the study of genetic material extracted directly from the stool microbiomes of people with PD and neurologically healthy control participants, was used by researchers at the University of Alabama at Birmingham in the US.
The gut microbiome is engaged...
IT & Data Management
Advent of Artificial Pancreas Technology Will Alter Lives
Innovative technology could help people with Type 1 diabetes who can't control their condition, and it will be made available to them. Additionally, the aid is going to be provided with little human involvement.
With the technology being referred to...
News
A Guide to Understanding Cloning
When most people hear the term ’cloning’, they immediately recollect the story of Dolly, the first sheep to be cloned. Out of 277 embryos, she was the only viable fetus. Dolly lived for seven years. Her creation caused huge...
News
Massive Life Sciences Mergers-Acquisitions To Occur In 2023
According to EY's 2023 M&A Firepower report, the life sciences sector has record levels of deal-making Firepower, which measures a company's ability to undertake M&A on the strength of its balance sheet.
M&A activity worldwide in 2022
In the first eleven...
Drug Research
The AMR Action Fund Invests in BioVersys in Fight Against Drug-Resistant Bacteria
The AMR Action Fund, a public-private partnership investing in biotech companies developing antimicrobials, has invested in BioVersys AG, a clinical-stage company based in Basel, Switzerland. The transaction marks the Fund's first investment in Europe and is an important step...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.